期刊文献+

IL-17、IL-35水平异常表达在溃疡性结肠炎发生发展中的意义

下载PDF
导出
摘要 研究发现IL-17、IL-35水平异常表达在溃疡性结肠炎发生发展中重要作用,本课题研究IL-17、IL-35水平变化在溃疡性结肠炎患者体内的表达意义,并进一步了解IL-17、IL-35的作用机制。
出处 《山东化工》 CAS 2021年第2期153-153,共1页 Shandong Chemical Industry
  • 相关文献

参考文献1

二级参考文献12

  • 1中华医学会消化病学分会炎症性肠病学组.炎症性肠病诊断与治疗的共识意见(2012年·广州).中华内科杂志,2012,17:763-781.
  • 2Vignali DA, Kuchroo VK. IL-12 family cytokines: immunological playmakers. Nat Immunol, 2012, 13(8):722-728.
  • 3Olson BM, Sullivan JA, Burlingham WJ. Interleukin 35: a key mediator of suppression and the propagation of infectious tolerance. Front Immunol, 2013, 4:315.
  • 4Wirtz S, Billmeier U, McHedlidze T, et al. Interleukin-35 mediates mucosal immune responses that protect against T-cell-dependent colitis. Gastroenterology, 2011, 141(5): 1875-1886.
  • 5Whitehead GS, Wilson RH, Nakano K, et al. IL-35 production by inducible costimulator (ICOS)-positive regulatory T cells reverses established IL-17-dependent allergic airways disease. J Allergy Clin Immunol, 2012, 129(1):207-215, el-e5.
  • 6Ma Y, Liu X, Wei Z, et al. The expression of a novel anti-inflammatory cytokine IL-35 and its possible significance in childhood asthma. Immunol Lett, 2014, 162(1 Pt A): 11-17.
  • 7Chen C, Deng Y, Chen H, et al. Decreased concentration of IL-35 in plasma of patients with asthma and COPD. Asian Pac J Allergy Immunol, 2014, 32(3):211-217.
  • 8Cai Z, Wong CK, Dong J, et al. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/Ipr mice. Clin Exp Immunol, 2015, 181(2):253-266.
  • 9Ouyang H, Shi YB, Liu ZC, et al. Decreased interleukin 35 and CD4+EBI3+ T cells in patients with active systemic lupus erythematosus. Am J Med Sci, 2014, 348(2): 156-161.
  • 10Nakano S, Morimoto S, Suzuki S, et al. Immunoregulatory role of IL-35 in T cells of patients with rheumatoid arthritis. Rheumatology (Oxford), 2015, 54(8): 1498-1506.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部